Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 154 entries
View as:

Body Composition in Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT02111538 Org: User:
Start: 02/28/14 End: 04/30/19 Due: 04/30/20

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

Phase: N/A Priority: Normal
NCT ID: NCT06917196 Org: User:
Start: 12/04/23 End: 06/04/26 Due: 06/04/27

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00916890 Org: User:
Start: 02/28/09 End: 12/31/15 Due: 12/31/16

Improving Immunosuppressive Therapy in Heart Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03932539 Org: User:
Start: 05/14/19 End: 12/31/21 Due: 12/31/22

Early IntraVenous Administration of Nutritional Support

Phase: N/A Priority: Normal
NCT ID: NCT03949907 Org: User:
Start: 04/14/20 End: 07/30/24 Due: 07/30/25

Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial

Phase: N/A Priority: Normal
NCT ID: NCT04399798 Org: User:
Start: 05/15/20 End: 11/15/20 Due: 11/15/21

Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)

Phase: N/A Priority: Normal
NCT ID: NCT00865722 Org: User:
Start: 03/31/09 End: 05/31/12 Due: 05/31/13

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT04392960 Org: User:
Start: 07/22/20 End: 06/30/25 Due: 06/30/26

Eltrombopag for Inherited Thrombocytopenias

Phase: N/A Priority: Normal
NCT ID: NCT02422394 Org: User:
Start: 04/30/15 End: 03/31/18 Due: 03/31/19

Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)

Phase: N/A Priority: Normal
NCT ID: NCT04995380 Org: User:
Start: 09/01/21 End: 10/01/22 Due: 10/01/23

Prospective Cardiac Ultrasound Imaging Study With Demonstrator

Phase: N/A Priority: Normal
NCT ID: NCT05850741 Org: User:
Start: 06/04/21 End: 02/03/22 Due: 02/03/23

T Regulatory Cells in Hemodialysis Patients: Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT02981992 Org: User:
Start: 02/28/11 End: 02/29/16 Due: 02/28/17

Unraveling Mechanism of Action of Extracorporeal Photopheresis in Heart and Lung Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT06899828 Org: User:
Start: 04/17/23 End: 07/31/24 Due: 07/31/25

Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT01511263 Org: User:
Start: 01/31/12 End: 07/31/16 Due: 07/31/17

Effect of a Food Supplement Based on Nigella Sativa Seeds Oil and Vitamin E on Glyco-lipid Parameters in Dysglycemic and Dyslipidemic Perimenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT06901076 Org: User:
Start: 03/12/24 End: 02/11/25 Due: 02/11/26

Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06899763 Org: User:
Start: 01/01/23 End: 12/31/24 Due: 12/31/25

Quality of Life Analysis in Bladder Pain Syndrome/Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT05630742 Org: User:
Start: 11/01/21 End: 09/01/22 Due: 09/01/23

Assessment and Prevention of Acute Post-herniotomy Pain

Phase: N/A Priority: Normal
NCT ID: NCT01345162 Org: User:
Start: 03/31/10 End: 05/31/12 Due: 05/31/13

Pre-operative Immuno-Nutrition in Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT06355518 Org: User:
Start: 04/30/24 End: 09/30/26 Due: 09/30/27

D Mannose for Prevention and Treatment of RUTIs

Phase: N/A Priority: Normal
NCT ID: NCT03790254 Org: User:
Start: 01/01/10 End: 12/25/18 Due: 12/25/19

Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT03467438 Org: User:
Start: 11/22/18 End: 04/01/21 Due: 04/01/22

Non Primary HCMV Infection: Natural History and Immune Response

Phase: N/A Priority: Normal
NCT ID: NCT06337955 Org: User:
Start: 06/06/17 End: 12/31/24 Due: 12/31/25

HCMV Breakthrough Infections During Letermovir Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT06339892 Org: User:
Start: 01/09/23 End: 03/31/26 Due: 03/31/27

Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes

Phase: N/A Priority: Normal
NCT ID: NCT06338306 Org: User:
Start: 01/07/22 End: 06/30/25 Due: 06/30/26

A Registry of AL Amyloidosis (ReAL)

Phase: N/A Priority: Normal
NCT ID: NCT04839003 Org: User:
Start: 02/27/20 End: 05/31/25 Due: 05/31/26